ACTU vs MSFT: Which Stock is Better?
Side-by-side comparison of Actuate Therapeutics Inc and Microsoft Corp in 2026
ACTU
Actuate Therapeutics Inc
$5.56
MSFT
Microsoft Corp
$454.79
Key Metrics Comparison
| Metric | ACTU | MSFT | Winner |
|---|---|---|---|
| Market Cap | $136.67M | $3.38T | MSFT |
| P/E Ratio | N/A | 36.30 | MSFT |
| EPS (TTM) | $N/A | $13.70 | MSFT |
| Revenue Growth | 0.0% | 14.9% | MSFT |
| Gross Margin | 0.0% | 68.8% | MSFT |
Analyze ACTU
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ACTU or MSFT a better investment?
Comparing ACTU and MSFT: Actuate Therapeutics Inc has a market cap of $136.67M while Microsoft Corp has $3.38T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ACTU and MSFT?
ACTU (Actuate Therapeutics Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ACTU or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ACTU or MSFT?
MSFT has higher revenue growth at 14.9% vs 0.0% for ACTU.
Which company is more profitable: ACTU or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.8% compared to 0.0% for ACTU.
Which is the larger company: ACTU or MSFT?
Microsoft Corp (MSFT) is larger with a market cap of $3.38T compared to $136.67M for ACTU.
Should I buy ACTU or MSFT in 2026?
Both ACTU and MSFT have investment merit. ACTU trades at $5.56 while MSFT trades at $454.79. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ACTU and MSFT stock?
Key differences: Market Cap ($136.67M vs $3.38T), P/E Ratio (N/A vs 36.3x), Revenue Growth (0.0% vs 14.9%), Gross Margin (0.0% vs 68.8%).